| 注册
首页|期刊导航|中国药房|成都地区17家医院2007-2009年抗肿瘤药利用分析

成都地区17家医院2007-2009年抗肿瘤药利用分析

苏娜 徐珽 唐尧

中国药房2011,Vol.22Issue(18):1651-1654,4.
中国药房2011,Vol.22Issue(18):1651-1654,4.

成都地区17家医院2007-2009年抗肿瘤药利用分析

Analysis of the Utilization of Antineoplastic Agents in 17 Hospitals of Chengdu Area during the Period of 2007-2009

苏娜 1徐珽 1唐尧1

作者信息

  • 1. 四川大学华西医院药剂科,成都市,610041
  • 折叠

摘要

Abstract

OBJECTIVE: To evaluate the utilization of antineoplastic agents in 17 hospitals of Chengdu area during 2007-2009.METHODS: By means of DDD, the utilization of antineoplastic agents in 17 hospitals of Chengdu area during 2007-2009 was analyzed statistically in respect of consumption sum and DDDs.RESULTS: The consumption sum of antineoplastic agents in Chengdu area during 2007- 2009 presented in rapid increasing tendency.Plant-sourced antitumor drug took up the prominent place in the list of consumption sum and DDDs among antineoplastic agents.CONCLUSION: Paclitaxel take up the important place in the list of consumption sum and DDDs of antineoplastic agents, showing a good market prospects.

关键词

抗肿瘤药/限定日剂量/用药频度

分类

医药卫生

引用本文复制引用

苏娜,徐珽 ,唐尧..成都地区17家医院2007-2009年抗肿瘤药利用分析[J].中国药房,2011,22(18):1651-1654,4.

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文